Effects of Vitamin E on Cardiovascular and Microvascular Outcomes in High-Risk Patients With Diabetes
Results of the HOPE Study and MICRO-HOPE Substudy
Article Information
vol. 25 no. 11 1919-1927
PubMed
Published By
Print ISSN
Online ISSN
History
- Published in print November 1, 2002.
Copyright & Usage
DIABETES CARE
Author Information
- Eva Lonn, MD MSC1,
- Salim Yusuf, MBBS, DPHIL1,
- Byrcon Hoogwerf, MD2,
- Janice Pogue, MSC1,
- Qilong Yi, PHD1,
- Bernard Zinman, MD3,
- Jackie Bosch, MSC1,
- Gilles Dagenais, MD4,
- Johannes F.E. Mann, MD5,
- Hertzel C. Gerstein, MD, MSC1 and
- on behalf of the Heart Outcomes Prevention Evaluation (HOPE) Investigators
- 1Department of Medicine and Population Health Institute, McMaster University, Hamilton, Ontario, Canada
- 2Department of Medicine, Cleveland Clinic Foundation, Cleveland, Ohio
- 3Department of Medicine, University of Toronto, Ontario, Canada
- 4the Quebec Heart Institute, Laval University, Ste-Foy, Quebéc, Canada
- 5Department of Nephrology and Hypertension, Schwabing General Hospital, Ludwig Maximilians University, Munchen, Germany
Statistics from Altmetric.com
Article usage
In this Issue
November 2002, 25(11)
Effects of Vitamin E on Cardiovascular and Microvascular Outcomes in High-Risk Patients With Diabetes
